Packaging and Labeling Controls: Reducing Hidden Errors Before They Escalate
Understand how to reduce hidden packaging and labeling errors in pharmaceutical manufacturing — covering proactive controls, AI-driven process improvements, and supply chain performance strategies.
Instructor
Michael Esposito
GMP Training & Document Management Specialist
What You'll Learn
About the event
About this event
Packaging and Labeling has been long known to occupy a critical role in the pharmaceutical supply chain, particularly during product launches because of their unique position between the conception of a product and its realization and distribution.
Changes brought about by AI and machine learning provide opportunities to improve cycle time and reduce error frequency. Incorporating Packaging and Labeling's role in driving process improvements requires that organizations take a proactive approach in decision-making, process mapping, and resource allocation to increase efficiency and production capability.
Pharmaceutical manufacturing is entering the AI era, with production increasing at a rate that was not possible with conventional manufacturing. Packaging and Labeling requirements, as with other supply chain activities, will likewise be affected, and with it the possibility for increased errors. Effective controls are necessary to enable Packaging and Labeling to keep pace with increased demand.
Code: FDB1286
Curriculum
Requirements
- Working in pharmaceutical, biotech, or regulated manufacturing environments
- Applicable to packaging, labeling, QA, regulatory affairs, operations, and production control professionals
Who Should Attend
Labeling and Packaging professionals, Regulatory Affairs, Quality Assurance, Operations, Production Control, Packaging Technology, Labeling Coordination, Package Engineers, Packaging Operations, Information Technology, Project Management, and Research and Development.
Areas Covered
Meet Your Instructor
Michael Esposito
GMP Training & Document Management Specialist
Michael Esposito has 30 years experience in the pharmaceutical industry and 13 years experience in GMP training and document management. He has worked for Wyeth Pharmaceuticals, Pfizer and Johnson & Johnson's McNeil Consumer Healthcare Division in areas including Packaging, Quality Assurance, Government Contracts, translations, systems training, and international operations. He collaborated in the development and implementation of the training portion of the Consent Decree workplan for McNeil and revised their introductory GMP course. He is a member of the training organization GMP TEA and is fully fluent in Spanish.
Event Details
Format
Recorded Webinar
Duration
1.5 hours
Certificate
Included
Access
Lifetime
Related Events
Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
Learn how AI/ML and real-time digital quality metrics build a continuous-improvement framework aligned with FDA regulatory expectations, 21 CFR Part 11, and GAMP®5.
Carolyn Troiano
AI in GMP: What the FDA Is Already Expecting - Before You Ask
FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.
Dr. Ginette Collazo
HPLC Analytical Method Development and Validation
Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.
Dr. John C. Fetzer